Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Clinical Study

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

Cite this Article

To cite this article please use the text below.

Gill David M, Stenehjem David D, Parikh Kinjal, Merriman Joseph, Sendilnathan Arun, Agarwal Archana M, Hahn Andrew W, Gupta Sumati, Tantravahi Srinivas Kiran, Samlowski Wolfram E and Agarwal Neeraj (2016) Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2 ecancer 10 676



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation